Why the study?
Does low-dose continuous infusion of hANP improve postoperative LV remodeling and reduce ischemia/reperfusion injury in patients undergoing scheduled CABG?
Does low-dose continuous infusion of hANP improve postoperative LV remodeling and reduce ischemia/reperfusion injury in patients undergoing scheduled CABG?
Low-dose continuous infusion of hANP during CABG may inhibit postoperative LV remodeling and reduce ischemia/reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Supports low-dose hANP during CABG to reduce arrhythmias and injury markers; extends cardioprotection evidence in cardiac surgery.
Sezai et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: